SANARA MEDTECH INC (SMTI) Stock Fundamental Analysis
USA - NASDAQ:SMTI - US79957L1008 - Common Stock
33.96 USD
-1.32 (-3.74%)
Overall SMTI gets a fundamental rating of 4 out of 10. We evaluated SMTI against 191 industry peers in the Health Care Equipment & Supplies industry. SMTI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, SMTI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year SMTI has reported negative net income.
SMTI had a positive operating cash flow in the past year.
In the past 5 years SMTI always reported negative net income.
In the past 5 years SMTI always reported negative operating cash flow.
1.2 Ratios
SMTI has a Return On Assets of -10.04%. This is in the better half of the industry: SMTI outperforms 61.78% of its industry peers.
SMTI's Return On Equity of -28.40% is in line compared to the rest of the industry. SMTI outperforms 57.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.04% | ||
| ROE | -28.4% | ||
| ROIC | N/A |
ROA(3y)-9.93%
ROA(5y)-19.18%
ROE(3y)-17.77%
ROE(5y)-30.01%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of SMTI (91.77%) is better than 98.95% of its industry peers.
In the last couple of years the Gross Margin of SMTI has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for SMTI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 91.77% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y0.2%
2. Health
2.1 Basic Checks
SMTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SMTI has more shares outstanding
Compared to 5 years ago, SMTI has more shares outstanding
Compared to 1 year ago, SMTI has a worse debt to assets ratio.
2.2 Solvency
SMTI has an Altman-Z score of 3.39. This indicates that SMTI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.39, SMTI is in the better half of the industry, outperforming 70.68% of the companies in the same industry.
The Debt to FCF ratio of SMTI is 1100.00, which is on the high side as it means it would take SMTI, 1100.00 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of SMTI (1100.00) is better than 64.40% of its industry peers.
A Debt/Equity ratio of 1.26 is on the high side and indicates that SMTI has dependencies on debt financing.
SMTI's Debt to Equity ratio of 1.26 is on the low side compared to the rest of the industry. SMTI is outperformed by 80.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.26 | ||
| Debt/FCF | 1100 | ||
| Altman-Z | 3.39 |
ROIC/WACCN/A
WACC8.54%
2.3 Liquidity
A Current Ratio of 2.27 indicates that SMTI has no problem at all paying its short term obligations.
SMTI's Current ratio of 2.27 is in line compared to the rest of the industry. SMTI outperforms 44.50% of its industry peers.
SMTI has a Quick Ratio of 2.03. This indicates that SMTI is financially healthy and has no problem in meeting its short term obligations.
SMTI has a Quick ratio (2.03) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.27 | ||
| Quick Ratio | 2.03 |
3. Growth
3.1 Past
SMTI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.97%.
SMTI shows a strong growth in Revenue. In the last year, the Revenue has grown by 34.54%.
SMTI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 49.08% yearly.
EPS 1Y (TTM)-48.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.9%
Revenue 1Y (TTM)34.54%
Revenue growth 3Y53.13%
Revenue growth 5Y49.08%
Sales Q2Q%28.14%
3.2 Future
The Earnings Per Share is expected to grow by 36.86% on average over the next years. This is a very strong growth
Based on estimates for the next years, SMTI will show a quite strong growth in Revenue. The Revenue will grow by 16.14% on average per year.
EPS Next Y12.32%
EPS Next 2Y24.6%
EPS Next 3Y36.86%
EPS Next 5YN/A
Revenue Next Year22.74%
Revenue Next 2Y18.51%
Revenue Next 3Y16.14%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SMTI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SMTI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
SMTI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SMTI is cheaper than 62.30% of the companies in the same industry.
SMTI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SMTI is cheaper than 64.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7556.1 | ||
| EV/EBITDA | 167.27 |
4.3 Compensation for Growth
SMTI's earnings are expected to grow with 36.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.6%
EPS Next 3Y36.86%
5. Dividend
5.1 Amount
No dividends for SMTI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:SMTI (9/12/2025, 8:17:38 PM)
33.96
-1.32 (-3.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners11.57%
Inst Owner Change19.28%
Ins Owners8.45%
Ins Owner Change0.25%
Market Cap302.24M
Analysts82.5
Price Target51 (50.18%)
Short Float %7.78%
Short Ratio4.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.38%
Min EPS beat(2)20.02%
Max EPS beat(2)48.75%
EPS beat(4)3
Avg EPS beat(4)15.39%
Min EPS beat(4)-53.45%
Max EPS beat(4)48.75%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.72%
Min Revenue beat(2)-2.13%
Max Revenue beat(2)0.69%
Revenue beat(4)2
Avg Revenue beat(4)0.29%
Min Revenue beat(4)-2.13%
Max Revenue beat(4)2.64%
Revenue beat(8)4
Avg Revenue beat(8)-1.06%
Revenue beat(12)5
Avg Revenue beat(12)-2.89%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.04%
PT rev (3m)2.04%
EPS NQ rev (1m)45.57%
EPS NQ rev (3m)52.75%
EPS NY rev (1m)37.18%
EPS NY rev (3m)48.01%
Revenue NQ rev (1m)3.3%
Revenue NQ rev (3m)3.3%
Revenue NY rev (1m)1.46%
Revenue NY rev (3m)0.78%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 3.1 | ||
| P/FCF | 7556.1 | ||
| P/OCF | 82.58 | ||
| P/B | 8.4 | ||
| P/tB | N/A | ||
| EV/EBITDA | 167.27 |
EPS(TTM)-1.16
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)0
FCFY0.01%
OCF(TTM)0.41
OCFY1.21%
SpS10.95
BVpS4.04
TBVpS-0.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.04% | ||
| ROE | -28.4% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 91.77% | ||
| FCFM | 0.04% |
ROA(3y)-9.93%
ROA(5y)-19.18%
ROE(3y)-17.77%
ROE(5y)-30.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y0.2%
F-Score4
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.26 | ||
| Debt/FCF | 1100 | ||
| Debt/EBITDA | 21.26 | ||
| Cap/Depr | 73.13% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 176.81% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.27 | ||
| Quick Ratio | 2.03 | ||
| Altman-Z | 3.39 |
F-Score4
WACC8.54%
ROIC/WACCN/A
Cap/Depr(3y)14.55%
Cap/Depr(5y)146.84%
Cap/Sales(3y)0.77%
Cap/Sales(5y)3.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.9%
EPS Next Y12.32%
EPS Next 2Y24.6%
EPS Next 3Y36.86%
EPS Next 5YN/A
Revenue 1Y (TTM)34.54%
Revenue growth 3Y53.13%
Revenue growth 5Y49.08%
Sales Q2Q%28.14%
Revenue Next Year22.74%
Revenue Next 2Y18.51%
Revenue Next 3Y16.14%
Revenue Next 5YN/A
EBIT growth 1Y32.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y100.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y163.76%
OCF growth 3YN/A
OCF growth 5YN/A